← Leaderboards
Suyu Shu
Cleveland Clinic Foundation
$4,156,854
Attributed
$4,156,854
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $313.6K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$4,156,854 · 5
By mechanism
R01$4,156,854 · 4
P01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Saikh J Haque$3,016,656
- Peter A Cohen$9,427,938
- Gregory E Plautz$2,534,015
- John K Cowell$13,718,674
Others in their field
Top investigators on “Neoplasm /Cancer Immunotherapy”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Charles A Coltman · Southwest Oncology Group$65,041,418
- Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Samuel A Wells · Duke University$32,148,803
- George Wilding · University Of Wisconsin Madison$22,104,400
Research focus
Neoplasm /Cancer ImmunotherapyDendritic CellsNeoplastic CellHybrid CellsLaboratory MouseNeoplasm /Cancer VaccineAntigen PresentationCell FusionNonhuman Therapy EvaluationBeta GalactosidaseDisease /Disorder ModelColony Stimulating FactorVaccine DevelopmentBiomedical Equipment DevelopmentMelanomaIonophoresModel Design /DevelopmentInterleukin 4Electric FieldClinical TrialsT LymphocyteEnzyme Linked Immunosorbent AssayImmune ResponseBreast Carcinoma
Grant awards (16)
Immunotherapy with Dendritic-Allogeneic Tumor Cells$255,020
R01 · FY2008 · CA · contact PI
Immunotherapy with Dendritic-Allogeneic Tumor Cells$42,378
R01 · FY2008 · CA · contact PI
Immunotherapy with Dendritic-Allogeneic Tumor Cells$297,398
R01 · FY2007 · CA · contact PI
Immunotherapy with Dendritic-Allogeneic Tumor Cells$306,280
R01 · FY2006 · CA · contact PI
Immunotherapy with Dendritic-Allogeneic Tumor Cells$313,650
R01 · FY2005 · CA
IMMUNOTHERAPY WITH ELECTROFUSED DENDRITIC TUMOR HYBRIDS$344,250
R01 · FY2004 · CA
Immunotherapy with Dendritic-Allogeneic Tumor Cells$313,650
R01 · FY2004 · CA
IMMUNOTHERAPY WITH ELECTROFUSED DENDRITIC TUMOR HYBRIDS$333,000
R01 · FY2003 · CA
IMMUNOTHERAPY WITH ELECTROFUSED DENDRITIC TUMOR HYBRIDS$333,000
R01 · FY2002 · CA
IMMUNOTHERAPY OF MELANOMA WITH DENDRITIC-TUMOR HYBRIDS$0
P01 · FY2002 · CA
IMMUNOTHERAPY WITH ELECTROFUSED DENDRITIC TUMOR HYBRIDS$333,000
R01 · FY2001 · CA
SYSTEMIC T CELL IMMUNOTHERAPY OF MALIGNANT GLIOMAS$245,045
R01 · FY2001 · CA
TUMOR THERAPY WITH ADOPTIVELY TRANSFERRED CD4 CELLS$236,066
R01 · FY2001 · CA
IMMUNOTHERAPY WITH ELECTROFUSED DENDRITIC TUMOR HYBRIDS$333,000
R01 · FY2000 · CA
SYSTEMIC T CELL IMMUNOTHERAPY OF MALIGNANT GLIOMAS$239,904
R01 · FY2000 · CA
TUMOR THERAPY WITH ADOPTIVELY TRANSFERRED CD4 CELLS$231,213
R01 · FY2000 · CA